Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Biorregulatory therapy significantly improved the dog's health, reversing previous issues and eliminating the need for ongoing medication.

Methylated gene parts may cause finasteride-resistance in some enlarged prostate patients.

Chemotherapy toxicity might be reduced by using DNA neutralizing agents.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

Taking cyproterone acetate and ethinyl oestradiol for hair loss can lower vitamin B12 levels in women.

β‐thymosins, especially thymosin β4, help in heart protection, wound healing, and hair growth by stabilizing actin in cells.

PTHrP is important for bone formation and may be targeted for osteoporosis treatment and longevity therapies.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

The 1298CC genotype in RA patients leads to higher methotrexate toxicity, while the 1298AA genotype results in better treatment response.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Both treatments help with hair regrowth in alopecia areata, but azathioprine has milder side effects than betamethasone.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Certain drugs that block specific enzymes can help treat prostate diseases.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

Topical 0.1% tacrolimus improved a rare ear condition in cats.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.